drugset / Trial / NCT04353024

Effects of Dimethyltryptamine in Healthy Subjects

NCT04353024

Phase 1 Completed 31 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverQuadruple-blindBasic science

Summary

N,N-dimethyltryptamine (DMT) is a naturally-occurring psychedelic substance widely used in recreational and spiritual settings. DMT can be used as a tool to induce an altered state of consciousness of interest in psychological and psychiatric research. DMT is rapidly metabolized by monoamine oxidase (MAO) A. Therefore, it is inactive when administered orally and has a very short duration of action when administered parenterally (\<20 min).Therefore, an intravenous administration regime including a bolus and maintenance perfusion has been proposed to induce a stable and prolonged DMT experience allowing to study the psychological and autonomic acute effects of DMT. This administration allows to induce and end an altered state safely and quickly. The goal of the present study is to experimentally test different intravenous DMT administration schedules to investigate the subjective and autonomic effects of DMT in healthy subjects.

Timeline

Start
2021-06-18
Primary completion
2022-08-29
Completion
2022-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Dimethyltryptamine Unknown 0.6 mg Intravenous
Subject Dimethyltryptamine Unknown 1 mg Intravenous

Indications

No indication recorded.